Paxlovid is only recommended for patients who exhibit mild to moderate symptoms.
Paxlovid will be available from May 30 at the Ministry of Post and Telecommunications – on Monivong Boulevard just north of the train station – at US$95 per five-day course, with a $US105 resale price cap, the NCCC said in a press statement.
Similarly, molnupiravir – locally marketed as Molnatris – for patients aged 18 and over, will still be on sale for US$50 a course at the telecoms ministry, with a US$60 resale price cap. Multiple orders for either drug must be placed at least one week apart, the NCCC said, warning that breaching price cap rules may result in legal action.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients(Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.
Read more »
KKM lapor 1,877 jangkitan baharu Covid-19 semalam | The Malaysian InsightDua kematian turut direkodkan yang menjadikan jumlah keseluruhan kepada 35,658.
Read more »
Covid-19 Watch: 1,845 new cases detected, active infections now at 25,189PETALING JAYA: Malaysia recorded 1,845 new Covid-19 cases on Thursday (May 26), bringing the total number of infections in the country since the pandemic began to 4,499,057.
Read more »
Covid-19: Kes positif menurunMalaysia semalam merekodkan penurunan kes positif Covid-19 dengan mencatatkan sebanyak 1,644 kes berbanding kelmarin, 1,873 kes.
Read more »